The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.
Feature | Cardiac Diagnostics | Steven D. Freedman, M.D., Ph.D.

In many cases, the diagnosis and management of patients with rare diseases can require the participation of ...

Home May 07, 2018
Home
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

Home May 07, 2018
Home
News

Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.

Home May 04, 2018
Home
Blog

In March, I made a day trip to New York City to receive the 2017 Jesse H. Neal Award for Best Use of Social Media. The ...

Home May 04, 2018
Home
Case Study | Cardiovascular Information Systems (CVIS)

Balancing high quality care with efficiency — and avoiding unnecessary procedures — is a priority for any hospital ...

Home May 04, 2018
Home
An 3D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.
Feature | Heart Valve Technology | Dave Fornell, Editor

May 4, 2018 — Transcatheter valve technology has been advancing very quickly and the links to aggregated content from ...

Home May 04, 2018
Home
News | Womens Cardiovascular Health

May 3, 2018 — The U.S. Food and Drug Administration (FDA) recently announced the availability of a draft guidance for ...

Home May 03, 2018
Home
Technology | EP Mapping and Imaging Systems

May 3, 2018 — APN Health LLC announced its Navik 3D mapping system is commercially released and in clinical use. The ...

Home May 03, 2018
Home
Technology | EP Mapping and Imaging Systems

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD Grid ...

Home May 03, 2018
Home
Technology | Drug-Eluting Balloons

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact Admiral ...

Home May 03, 2018
Home
Technology | Intravascular Imaging

May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Home May 02, 2018
Home
News | Congenital Heart

Select adult patients born with a single functioning ventricle, and who have undergone a surgical operation called the ‘Fontan procedure’ during childhood, are being enrolled in a new global-first clinical trial. The trial, led by a multi-disciplinary team of heart and lung physicians, will examine the effects of a portable, non-invasive medical device never before tested on patients with this cardiac condition.

Home May 02, 2018
Home
News | Artificial Intelligence

May 2, 2018 – The Board of Directors of the Radiological Society of North America (RSNA) announced that Charles E. Kahn ...

Home May 02, 2018
Home
360 Photos | Stroke

This is a 360 degree view inside the back of the Northwestern Medicine Central DuPage Hospital Mobile Stroke Unit ...

Home May 01, 2018
Home
News | Computed Tomography (CT)

James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of Cardiovascular Computed Tomography (JCCT). He in turn has named Todd C. Villines, M.D., FSCCT, as executive editor along with Gudrun Feuchtner, M.D.

Home May 01, 2018
Home
Subscribe Now